Cancer cells are on the move in the bloodstream in the very early stage of pancreatic cancer. And it can be detected before cancer is diagnosed, claims research by the University of Michigan Health System. In a study of 51 patients, researchers used a state-of-the art microfluidic device to capture circulating pancreas epithelial cells in 33 percent of patients with early pancreatic lesions and no clinical diagnosis of cancer. The findings, published ...
Read More
You have just read an article categorized health
titled Microfluidic Device Captures Potential Biomarker for Early Pancreatic Cancer.
Written by:
editor -
Thursday, May 1, 2014
There are currently no comments for "Microfluidic Device Captures Potential Biomarker for Early Pancreatic Cancer"
Post a Comment